ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00022971
Recruitment Status : Terminated
First Posted : August 20, 2001
Last Update Posted : April 19, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )